Uptake and delivery of antigens by mesenchymal stromal cells

Cytotherapy

Volumn 15, Issue 6, 2013, Pages 673-678

  Sánchez Abarca, Luis Ignacio ^a   Álvarez Laderas, Isabel ^a   Díez Campelo, María ^b   Caballero Velázquez, Teresa ^a   Herrero, Carmen ^b   Muntión, Sandra ^b   Calderón, Cristina ^a   García Guerrero, Estefanía ^a   Sánchez Guijo, Fermín ^b   Del Cañizo, Consuelo ^b   San Miguel, Jesús ^b   Pérez Simón, José Antonio ^a  

^a HOSPITAL UNIVERSITARIO VIRGEN DEL ROCÍO   (Spain)

^b HOSPITAL UNIVERSITARIO DE SALAMANCA   (Spain)

Author keywords

carrier; endocytic capacity; mesenchymal stromal cells; pinocytic capacity

Indexed keywords

B7 ANTIGEN; CD86 ANTIGEN; FLUORESCEIN ISOTHIOCYANATE DEXTRAN; HLA DR ANTIGEN; MANNOSE RECEPTOR;

ADIPOGENESIS; ANTIGEN PRESENTING CELL; ARTICLE; BONE DEVELOPMENT; BONE MARROW CELL; CELL DIFFERENTIATION; CELL LYSATE; CONTROLLED STUDY; DENDRITIC CELL; ENDOCYTOSIS; HUMAN; HUMAN CELL; MESENCHYMAL STROMA CELL; PERIPHERAL BLOOD MONONUCLEAR CELL; PHENOTYPE; PINOCYTOSIS; PRIORITY JOURNAL; T LYMPHOCYTE;

ANTIGEN-PRESENTING CELLS; DENDRITIC CELLS; ENDOCYTOSIS; HLA-D ANTIGENS; HUMANS; IMMUNOSUPPRESSIVE AGENTS; LECTINS, C-TYPE; MANNOSE-BINDING LECTINS; MESENCHYMAL STEM CELL TRANSPLANTATION; MESENCHYMAL STROMAL CELLS; MULTIPOTENT STEM CELLS; PINOCYTOSIS; RECEPTORS, CELL SURFACE; T-LYMPHOCYTES;

EID: 84877311317     PISSN: 14653249     EISSN: 14772566     Source Type: Journal    
DOI: 10.1016/j.jcyt.2013.01.216     Document Type: Article

References (32)

1. M. Dominici, K. Le Blanc, I. Mueller, I. Staper Cortenbach, F. Marini, and D. Krause Minimal criteria for defining multipotent mesenchymal stromal cells. The International Society for Cellular Therapy position statement Cytotherapy 8 2006 315 317
2. J.A. Perez Simon, O. Lopez-Villar, E.J. Andreu, J. Rifon, S. Muntion, and M. Diez-Campelo Mesenchymal stem cells expanded with human serum for the treatment of acute and chronic graft-versus-host disease: results of a phase I/II clinical trial Haematologica 96 2011 1072 1076
3. K. Le Blanc, and O. Ringdén Immunomodulation by mesenchymal stem cells and clinical experience J Intern Med 262 2007 509 525
4. J. García-Castro, C. Trigueros, J. Madrenas, J.A. Pérez-Simón, R. Rodríguez, and P. Menéndez Mesenchymal stem cells and their use as cell replacement therapy and disease modelling tool J Cell Mol Med 12 2008 2552 2565
5. A.J. Nauta, and W.E. Fibbe Immunomodulatory properties of mesenchymal stromal cells Blood 110 2007 3499 3506
6. K. Le Blanc, and O. Ringdén Mesenchymal stem cells: properties and role in clinical bone marrow transplantation Curr Opin Immunol 18 2006 586 591
7. A. Uccelli, L. Moretta, and V. Pistoia Mesenchymal stem cells in health and disease Nat Rev Immunol 8 2008 726 736
8. Y. Shi, G. Hu, J. Su, W. Li, Q. Chen, and P. Shou Mesenchymal stem cells: a new strategy for immunosuppression and tissue repair Cell Res 20 2010 510 518
9. W. Zhang, W. Ge, C. Li, S. You, L. Liao, and Q. Han Effects of mesenchymal stem cells on differentiation, maturation, and function of human monocyte-derived dendritic cells Stem Cells Dev 13 2004 263 271
10. W.T. Tse, J.D. Pendleton, W.M. Beyer, M.C. Egalka, and E.C. Guinan Suppression of allogeneic T-cell proliferation by human marrow stromal cells: implications in transplantation Transplantation 75 2003 389 397
11. K. Bieback, A. Hecker, A. Kocaömer, H. Lannert, K. Schallmoser, and D. Strunk Human alternatives to fetal bovine serum for the expansion of mesenchymal stromal cells from bone marrow Stem Cells 27 2009 2331 2341
12. E.M. Horwitz, P.L. Gordon, W.K. Koo, J.C. Marx, M.D. Neel, and R.Y. McNall Isolated allogeneic bone marrow derived mesenchymal stem cells engraft and stimulate growth in children with osteogenesis imperfecta: implications for cell therapy of bone Proc Natl Acad Sci U S A 99 2002 8932 8937
13. K. Le Blanc, L. Tammik, B. Sundberg, S.E. Haynesworth, and O. Ringden Mesenchymal stem cells inhibit and stimulate mixed lymphocyte cultures and mitogenic responses independently of the major histocompatibility complex Scand J Immunol 57 2003 11 20
14. J.L. Chan, K.C. Tang, A.P. Patel, L.M. Bonilla, N. Pierobon, and N.M. Ponzio Antigen presenting property of mesenchymal stem cells occurs during a narrow window at low levels of interferon-gamma Blood 107 2006 4817 4824
15. J. Stagg, S. Pommey, N. Eliopoulos, and J. Galipeau Interferon-gamma- stimulated marrow stromal cells: a new type of nonhematopoietic antigenpresenting cell Blood 107 2006 2570 2577
16. M. François, R. Romieu-Mourez, S. Stock-Martineau, M.N. Boivin, J.L. Bramson, and J. Galipeau Mesenchymal stromal cells cross-present soluble exogenous antigens as part of their antigen-presenting cell properties Blood 114 2009 2632 2638
17. J. Corre, K. Mahtouk, M. Attal, M. Gadelorge, A. Huynh, and S. Fleury-Cappellesso Bone marrow mesenchymal stem cells are abnormal in multiple myeloma Leukemia 21 2007 1079 1088
18. E.M. Villaron, J. Almeida, N. López-Holgado, M. Alcoceba, L.I. Sánchez-Abarca, and F.M. Sánchez-Guijo Mesenchymal stem cells are present in peripheral blood and can engraft after allogeneic hematopoietic stem cell transplantation Haematologica 89 2004 1421 1427
19. B. Blanco, J.A. Pérez-Simón, L.I. Sánchez-Abarca, X. Carvajal-Vergara, J. Mateos, and B. Vidriales Bortezomib induces selective depletion of alloreactive T lymphocytes and decreases the production of Th1 cytokines Blood 107 2006 3575 3583
20. J. Almeida, C. Bueno, M.C. Alguero, M.L. Sanchez, M.C. Cañizo, and M.E. Fernandez Extensive characterization of the immunophenotype and pattern of cytokine production by distinct subpopulations of normal human peripheral blood MHC II+/lineage-cells Clin Exp Immunol 118 1999 392 401
21. - dendritic cells Clin Immunol 100 2001 325 338
22. J. Stagg Immune regulation by mesenchymal stem cells: two sides to the coin Tissue Antigens 69 2007 1 9
23. S. Tabera, J.A. Pérez-Simón, M. Díez-Campelo, L.I. Sánchez-Abarca, B. Blanco, and A. López The effect of mesenchymal stem cells on the viability, proliferation and differentiation of B-lymphocytes Haematologica 93 2008 1301 1309
24. L. Sánchez, I. Gutierrez-Aranda, G. Ligero, R. Rubio, M. Muñoz-López, and J.L. García-Pérez Enrichment of human ESC-derived multipotent mesenchymal stem cells with immunosuppressive and anti-inflammatory properties capable to protect against experimental inflammatory bowel disease Stem Cells 29 2011 251 262
25. C. Shi Recent progress toward understanding the physiological function of bone marrow mesenchymal stem cells Immunology 136 2012 133 138
26. K. Kollar, E. Seifried, and R. Henschler Therapeutic potential of intravenously administered human mesenchymal stromal cells Hamostaseologie 31 2011 269 274
27. R. Romieu-Mourez, M. François, M.N. Boivin, M. Bouchentouf, D.E. Spaner, and J. Galipeau Cytokine modulation of TLR expression and activation in mesenchymal stromal cells leads to a proinflammatory phenotype J Immunol 182 2009 7963 7973
28. J.L. Spees, C.A. Gregory, H. Singh, H.A. Tucker, A. Peister, and P.J. Lynch Internalized antigens must be removed to prepare hypoimmunogenic mesenchymal stem cells for cell and gene therapy Mol Ther 9 2004 747 756
29. M. Sundin, O. Ringdén, and B. Sundberg No alloantibodies against mesenchymal stromal cells, but presence of anti-fetal calf serum antibodies, after transplantation in allogeneic hematopoietic stem cell recipients Haematologica 92 2007 1208 1215
30. D.M. Underhill, and H.S. Goodridge Information processing during phagocytosis Nat Rev Immunol 12 2012 492 502
31. O. Delarosa, W. Dalemans, and E. Lombardo Toll-like receptors as modulators of mesenchymal stem cells Front Immunol 3 2012 182
32. I. Zanoni, R. Ostuni, L.R. Marek, S. Barresi, R. Barbalat, and G.M. Barton CD14 controls the LPS-induced endocytosis of Toll-like receptor 4 Cell 147 2011 868 880